recombinant vaccinia-B7.1 vaccine

BIOLOGICAL3 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Melanoma (Skin)Prostate Cancer

Phase 1

Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

CompletedNCT00004148

National Cancer Institute (NCI)Melanoma (Skin)

Start: 1999-10-31Updated: 2013-02-11

Phase 2

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

CompletedNCT00045227

National Cancer Institute (NCI)Prostate Cancer

Start: 2002-08-31End: 2007-10-31Updated: 2013-06-19

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

CompletedNCT00020254

National Cancer Institute (NCI)Prostate Cancer

Start: 2000-06-30Updated: 2015-04-29